Oral Contraceptive Pill (OCP) Pharmacogenomics

PHASE4RecruitingINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions

ContraceptionPharmacogenomic Drug Interaction

Interventions

DRUG

Desogestrel / Ethinyl Estradiol Pill

Standard pill packs containing 21 active pills and 7 placebo pills

Trial Locations (2)

NOT_YET_RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

RECRUITING

Yale University, New Haven

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Yale University

OTHER

NCT06334315 - Oral Contraceptive Pill (OCP) Pharmacogenomics | Biotech Hunter | Biotech Hunter